Signos
Company

Last deal

Amount

Series B

Stage

21.10.2023

Date

4

all rounds

$17M

Total amount

General

About Company
Signos uses AI and glucose data to help people achieve healthy weight loss.

Industry

Sector :

Subsector :

Keywords :

founded date

16.09.2020

Number of employees

Company Type

Non-profit

Last funding type

Series B

IPO status

Private

Description

Signos is a weight loss application that combines continuous glucose monitoring with an AI-enhanced app to provide personalized recommendations for meals and exercises. By visualizing metabolism in real-time, users can track their glucose count and keep their diet under control. The platform is designed to tackle the obesity epidemic by offering a new way for people to act on their body's unique response to what they eat. With the help of Signos, users can transform their weight loss journey from diets that don't work to plans that do.
Contacts

Phone number

Social url